Stock Market News

2 weeks The Weight-Loss Battle That Could Rattle Eli Lilly’s $100 Billion Market Investor's Business Daily

An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in weight-loss drugs.
The post The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market appeared first on Investor&#039…

Eli Lilly (LLY) · Pharmaceuticals

10 hours Eli Lilly’s Alzheimer’s treatment approved in China Investing.com

11 hours Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com

14 hours Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks

19 hours Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

20 hours NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

21 hours 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

22 hours Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks

1 day Eli Lilly: A Rare Buying Opportunity Seeking Alpha

2 days Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks

2 days BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

2 days Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily

2 days EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks

3 days Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha

3 days Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha

5 days Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com

5 days Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks

6 days Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks

6 days Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? Zacks

6 days Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks

6 days Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025 Yahoo Finance

7 days Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable Seeking Alpha

7 days Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

7 days Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low Seeking Alpha

7 days Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha

7 days How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

7 days Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly CNBC

1 week Eli Lilly to test obesity drugs to treat addiction in 2025, CEO says #shorts #weightloss #zepbound YouTube

1 week Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks

1 week Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations Seeking Alpha

1 week Eli Lilly to test obesity drugs for smoking, alcohol abuse – Bloomberg Investing.com

1 week Here’s Why Agios Stock Plummeted More Than 20% on Monday Zacks

1 week Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks

1 week Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose Investing.com

1 week Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15% Zacks

1 week Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Zacks

1 week The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

1 week Eli Lilly announces $15 billion buyback, dividend hike Investing.com

1 week Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

1 week Netflix, Eli Lilly among Monday’s market cap stock movers Investing.com

1 week BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy Seeking Alpha

1 week Agios Crashes 21% After A Surprise Side Effect Hammered Its ‘Very Safe’ Drug Investor's Business Daily

1 week Catalyst Pharmaceuticals: Agamree Is Its Key To A Sustainable Future Seeking Alpha

1 week Eli Lilly Stock Just Got Even Sweeter. Here’s Why It’s Worth Buying Now Yahoo Finance

1 week The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

2 weeks Rhythm Pharmaceuticals: A Key Year Ahead Seeking Alpha

2 weeks Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound? Zacks

2 weeks Acadia (ACAD) Down 2.9% Since Last Earnings Report: Can It Rebound? Zacks

2 weeks Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks

2 weeks Down -54.05% in 4 Weeks, Here’s Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround Zacks

2 weeks Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.